Boston Scientific Q4 Earnings Preview: Analysts Expect 11.4% EPS Growth

Boston Scientific Corp. (BSX) is expected to announce its Q4 2025 earnings before the market opens on Feb. 4. Analysts predict a profit of $0.78 per share, up 11.4% YoY, and a full-year EPS of $3.04, up 21.1% from fiscal 2024. BSX stock has underperformed the S&P 500 Index and the Health Care Select Sector SPDR Fund over the past 52 weeks. Analysts' consensus opinion on BSX stock is bullish, with a "Strong Buy" rating and an average analyst price target of $126.80, indicating a potential upside of 28.5% from current levels.